Table 2.
Antibiotic prescription, dose and duration in the case of community-acquired pneumonia
| Antibiotic | N indications | Dose* | Indicated dose ≥ recommendation | Duration < 7 days | Duration 7 - 10 days | Duration > 10 days |
|---|---|---|---|---|---|---|
| Beta-lactams | 29/68 (42.7) | |||||
| Ceftriaxone | 20/68 (29.4) | 2.0 (2.0 - 3.5) | 19/20 (95.0) | 0/20 (0) | 17/20 (85.0) | 3/20 (15.0) |
| Cefepime | 5/68 (7.4) | 6.0 (5.0 - 6.0) | 4/5 (80.0) | 0/5 (0) | 3/5 (60.0) | 2/5 (40.0) |
| Meropenem | 4/68 (5.9) | 3.0 (1.9 - 3.0) | 3/4 (75.0) | 0/4 (0) | 3/4 (75.0) | 1/4 (25.0) |
| Macrolides | 19/68 (27.9) | |||||
| Clarithromycin | 10/68 (14.7) | 1.0 (0.9 - 1.0) | 8/10 (80.0) | 0/10 (0) | 8/10 (80.0) | 2/10 (20.0) |
| Azithromycin | 9/68 (13.2) | 0.5 (0.5 - 1.0) | 9/9 (100) | 0/9 (0) | 7/9 (77.8) | 2/9 (22.2) |
| Quinolones | 8/68 (11.8) | |||||
| Levofloxacin | 4/68 (5.9) | 0.8 (0.6 - 0.8) | 3/4 (75.0) | 0/4 (0) | 4/4 (100) | 0/4 (0) |
| Moxifloxacin | 4/68 (5.9) | 0.4 (0.4 - 1.3) | 4/4 (100) | 0/4 (0) | 4/4 (100) | 0/4 (0) |
| Glycopeptides | 4/68 (5.9) | |||||
| Vancomycin | 4/68 (5.9) | 2.0 (2.0 - 2.0) | 4/4 (100) | 0/4 (0) | 3/4 (75.0) | 1/4 (25.0) |
| Others | 8/68 (11.8) |
Results are expressed as the absolute values and percentages: n (%);
*
result is expressed as the median and interquartile range.